Review
Nature Reviews Cancer 4, 371-380 (May 2004) | doi:10.1038/nrc1365
Molecules and mechanisms of the graft-versus-leukaemia effect
Marie Bleakley1 & Stanley R. Riddell1 About the authors
Abstract
The ability of allogeneic bone-marrow cells and peripheral-blood stem cells to cure leukaemia remains the most striking example of the ability of the human immune system to recognize and destroy tumours. However, harnessing this 'graft-versus-leukaemia' effect to improve outcome for patients with advanced disease and segregating it from graft-versus-host disease have proven to be key challenges. The recent identification of molecules that are specifically expressed by leukaemic cells and that can be recognized by T cells has indicated that immunological reactivity can be targeted. This anticancer specificity of T cells should soon be routinely incorporated into allogeneic stem-cell transplant regimens to promote tumour eradication.
- View At a Glance
Author affiliations
- Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue, Seattle, Washington 98109, USA.
Correspondence to: Stanley R. Riddell1 Email: sriddell@fhcrc.org
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic?ischemic ratsJournal of Cerebral Blood Flow & Metabolism Original Article
Is the nitric oxide system involved in genetic hypertension in Dahl rats?Kidney International Original Article
Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potentialKidney International Original Article
See all 47 matches for Research